Breaking News
Revolutionizing Rare Disease Therapeutics A Partnership Between Invitae and BridgeBio Pharma
On January 30, 2024, Invitae, a renowned medical genetics company, made a groundbreaking announcement regarding their partnership with BridgeBio Pharma,...
Malibu Boats Remains Optimistic Despite Decline in Earnings
On January 30, 2024, Malibu Boats announced a decline in earnings during the second quarter of fiscal 2023. Their net...
NioCorp Developments and Brunel University London Partner to Revolutionize the Automotive Industry with AluminumScandium Alloys
On January 30, 2024, NioCorp Developments Ltd. announced a groundbreaking partnership with Brunel University London to revolutionize the automotive industry....
Betsy Graseck Maintains Underweight Rating on PNC Financial Services Group with Revised Price Target
On January 30, 2024, Betsy Graseck, an analyst at Morgan Stanley, expressed her bearish sentiment towards PNC Financial Services Group...
Deutsche Bank Analyst Initiates Coverage on Sabra Health Care REIT with a Buy Rating and 21 Price Target
On January 30, 2024, Deutsche Bank analyst Omotayo Okusanya made a significant move by initiating coverage on Sabra Health Care...
Cambridge NASDAQ CATC Surprises Investors with Strong Quarterly Earnings and Sales Figures
On January 30, 2024, Cambridge (NASDAQ: CATC) pleasantly surprised investors with its quarterly earnings. The company reported earnings of $1.11...
Johnson Controls Explores Strategic Alternatives for NonCommercial Businesses
On January 30, 2024, Johnson Controls made a significant announcement regarding its non-commercial businesses. The company revealed that it has...
Morgan Stanley Analyst Upgrades Price Target for Regions Financial
On January 30, 2024, Betsy Graseck, a renowned analyst at Morgan Stanley, expressed her optimistic view on Regions Financial (NYSE:RF)...
CanFite Expands Licensing Agreement to Include Pancreatic Cancer Indication
On January 30, 2024, Can-Fite BioPharma Ltd. announced the expansion of its out-licensing agreement with Ewopharma AG, encompassing the inclusion...
Mixed Analyst Sentiments and Price Targets for SL Green Realty
As of January 30, 2024, the outlook for SL Green Realty (NYSE:SLG) is varied, with analysts expressing both bullish and...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
